New manufacturing facility could drive gold standard in cell therapy
European Pharmaceutical Review
SEPTEMBER 21, 2023
A new Denmark-based manufacturing facility is set to establish the final development steps and upscaling of cell therapies. Partly due to this and due to the explorative phase cell therapy is in, it is very expensive to develop and manufacture cell therapies, so there simply are not many facilities doing it.”
Let's personalize your content